fda approval semaglutide approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults High-Dose Wegovy Wins FDA Approval

In this comprehensive guide, well break down the scientific data, set appropriate expectations, and offer practical next steps if your results fall short, plus insights into alternatives like bariatric surgery and specialized diets for diabetes

Quick Answer: Weight loss may not occur on semaglutide due to insufficient dosing, inadequate treatment duration, suboptimal lifestyle modifications, metabolic adaptation, or interfering medications

Some of this content was generated with AI assistance

00:21:37 Jennifer Trujillo And a lot of times, I think these days, were trying to make 00:21:41 Jennifer Trujillo room for the agents that also have added benefits beyond glucose control

Without creatine supplementation, the same person might show creatinine of 0.9 mg/dL and eGFR of 105, which is perfectly normal